A recent pilot offers business leaders a strategic case study on how regulatory sandboxes can enable infrastructure ...

Beta Bionics, Inc. (NASDAQ:BBNX) Q4 2025 Earnings Call Transcript February 18, 2026 Operator: Good day, and thank you for standing by. Welcome to the Beta Bionics Inc. Q4 and Full Year 2025 Earnings ...

From prior authorization delays to PBM reforms and Medicaid gaps, experts track policy shifts that shape health equity and ...

Third party commercial assessment shows larger than expected potential total addressable market for IGALMI® in the at-home setting ...

The outlook for drug development to treat rare diseases looks encouraging, offering hope to the 300 million people globally facing the significant challenges of these often-overlooked conditions.

On February 3, 2026, Congress passed – and the President signed – the Consolidated Appropriations Act, 2026 (2026 CAA). The ...

Thank you, and welcome to everybody joining us today. Alongside this, we're continuing to make excellent progress in R&D, ...

On January 30, 2026, the Department of Labor released a proposed rule (Proposed Rule) that would end long‑running confusion about how ERISA disclosure obligations apply to PBMs under the Consolidated ...

Neurocrine Biosciences, Inc. today announced its financial results for the fourth quarter ended December 31, 2025. "Our ...

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

Help us make Medscape the best clinical resource possible. Please use this form to submit your questions or comments on how to make this resource center more useful to clinicians.